World Hemophilia Treatment Market Share by 2022-2032: Upcoming Trends and Analysis

 

According to an analysis by Future Market Insights (FMI), the Hemophilia Treatment Market is expected to be valued at US$ 17.92 Bn in 2032, with a 4.8% CAGR during the forecast period.

Hemophilia therapy has improved dramatically in recent years due to the introduction of new products. In addition, several government and non-government groups are stepping forward to raise awareness of hemophilia symptoms, diagnosis, and treatment.

To remain ‘ahead’ of your competitors, request for a sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-14324

The high prevalence of hemophilia drives the significant need for quality hemophilia treatment. As a result, several countries are developing creative techniques to improve access to high-quality care for hemophiliacs. For example, innovative methods have been created in Germany to improve the monitoring of these and other associated disorders.

Furthermore, in recent years, awareness of the need for early-stage diagnosis and treatment and its potential impact has increased dramatically throughout European countries, driving demand for a product that would greatly simulate market income. The high prevalence of hemophilia drives the significant need for quality hemophilia treatment.

The high expense of hemophilia therapy, on the other hand, may have a negative impact on market growth. According to the National Hemophilia Foundation, the average cost of hemophilia treatment is over USD 300,000 per year, which has a substantial influence on operation margins, especially in today's capitated reimbursement environment.

The emergence of the COVID-19 pandemic slightly impacted the hemophilia treatment market negatively, owing to disruption in the global supply chain and logistics. Furthermore, the impact of the coronavirus outbreak on the industry peaked during early 2020, wherein patients suffering from such ailments were at a higher risk of suffering from coronavirus as they were more prone to infectious diseases.

Owing to these factors, the hemophilia treatment market is expected to reach US$ 16.5 Bn in 2027.

Key Takeaways:

  • Hemophilia A, a disease segment accounting for around 82% of the total revenue share, dominated the market in 2021.
  • In 2021, the adult patient category was worth USD 6,898 million. Hemophilia is becoming more common in the adult population.
  • In 2021, the prophylaxis segment was worth USD 7,998 million. This preventive medication helps to decrease hemophilic arthropathy and disability and the need for orthopedic surgery, resulting in a better quality of life.
  • During the forecast period, the injectables segment is predicted to grow at a rate of over 4.9 percent due to the effective method of drug administration.

Competitive Landscape:

Some of the major key players in hemophilia treatment markets are Bayer Healthcare, Biogen, Biotest AG, CSL Behring, Ferring B.V., Genentech, Kedrion, Novo Nordisk, and Octapharma, among others.

Major important players have used advanced technologies to meet the needs of consumers and gain a substantial market share.

  • Novo Nordisk received FDA approval for its biologics license application for Esperoct in February 2019. This medication is intended to reduce the frequency of bleeding episodes in children and adults with congenital factor VIII deficiency. This launch aided the corporation in introducing new items, giving it a competitive advantage.
  • Valoctocogene roxaparvovec (valrox) is a novel hemophilia gene therapy treatment developed by BioMarin that eliminates all bleeds and injects blood clotting factor VIII (FVIII) in patients, is expected to get FDA clearance in 2020.
  • Bayer Healthcare gained FDA approval for a new prolonged half-life hemophilia treatment in August 2018. A product for patients aged 12 and up. Jivi is a rFVIII replacement therapy that has been licensed for the treatment of bleeding. This approval aided the corporation in broadening its product offering globally.

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
​United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Comments

Post a Comment

Popular posts from this blog

Online Grocery Market Share, Development by Companies Future Investments and Key Opportunities by 2032

  The online grocery market has experienced tremendous India online grocery market growth over the past few months as a result of changing consumer lifestyles, increasing urbanization, and the tech-savvy generation that favours online shopping. The India online grocery market size has been estimated at USD 4,540.0 Million in 2022 and is projected to grow at a CAGR of 32.7% from 2022 to 2032, reaching USD 76,761.0 Million by that time which surges the India online grocery market key trends and opportunities. For more Information, Download Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15211 KEY TAKEAWAYS: Through 2032, the others segment of the India online grocery market share, which falls under the product type category, is anticipated to grow at a CAGR of 35.8%. The fresh produce segment of the India online grocery market size, which falls under the product type category, is anticipated to grow at a CAGR ...
Read more

Global Glucosamine Market by System Type, Revenue Analysis, By Region, Industry Analysis and Forecast, 2022-2027

Glucosamine is a naturally occurring compound within the cartilage of joints, it is made from chains of sugars and proteins bound together. Glucosamine is derived from shellfish that has been found to provide relief from minor pain. This naturally derived compound helps in formation of cartilage and synovial fluid which helps in maintaining joint health. Glucosamine is primarily used to ease symptoms of osteoarthritis, it can be taken by natural food supplements such as bone broth or glucosamine supplements available in the market in numerous formulations. Apart from its therapeutic use glucosamine is also used in cosmetic products, as it supports formation of connective tissue and helps increasing moisture and promotes exfoliation and hydration. These fundamental properties of glucosamine have encouraged the manufacturers to introduce new products and thus leading to overall growth of glucosamine market. Glucosamine Market Segmentation: Glucosamine is segmented on the basis of ...
Read more

Palm Oil & Mid-Fraction Market Analysis of Key Findings, and New Market Opportunities Explored by 2022-2032

  Palm Oil & mid-fraction is a preferred derivative over other palm oil co-products due to its functionality to yield higher shelf-life stability in the end-use products. It is generally fractionated to separate its content (mainly containing stearin and olein) through fractionation. When these phases are given a double-fractionation treatment, it gives to rise to palm mid-fraction. Palm oil & mid fraction is rich in content such as tocopherol and carotene and is used mainly in the production of edible fats and butter substitutes. Palm-oil manufactured for industrial processes are used in various forms of derivatives. Along with shelf life stability, the Palm oil & mid fraction also yields a good texture and volume in the bakery fat applications. The major processing of palm mid-fraction takes place mainly in South East Asian countries- Malaysia and Indonesia, from where it is exported to the rest of regions. Palm mid-fraction happens to be a primer in the pro...
Read more